BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
SLC12A1
,
calcium channel activity
,
Diabetes mellitus
,
Intestine
,
Pharmacogenetics
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
UK-103 320
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for UK-103 320
Explore Curated Studies Results
Literature
Most Relevant Literature
Quantitative determination of sildenafil (Viagra) and its metabolite (UK-103,320) in fluid and tissu…
Solid phase extraction and liquid chromatographic determination of sildenafil and N-demethylsildenaf…
A fatal hypotension by sildenafil in an end-stage renal disease patient with hypertension and abnorm…
Simultaneous determination of sildenafil and its active metabolite UK-103,320 in human plasma using …
Population pharmacokinetics of sildenafil in term neonates: evidence of rapid maturation of metaboli…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Food Effect Study For New Formulation
Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension
Blood Pressure Interaction Between Sildenafil and Sublingual Glyceryl Trinitrate (GTN) in Men With A…
Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension
A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persisten…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ